SF 1077 Senate Long Description
3E Relating to human services
ARTICLE 1 - LICENSING
Modifying provisions relating to chemical and mental health and human services licensing; requiring providers licensed to provide opioid addiction chemical dependency treatment services to provide educational information; establishing methadone treatment program standards for opioid addiction; providing policies and procedures for exceeding standards in the administrative rule; defining certain terms; providing regulations for medication orders, drug testing, criteria for unsupervised use, restrictions for unsupervised or take-home use, restriction exceptions, guest dosing, data and reporting, and nonmedication treatment services documentation; requiring review of the board of pharmacy prescription monitoring program (PMP); requiring department of human services licensed providers to develop and maintain certain policies and procedures and to develop and maintain a quality improvement process and plan; specifying certain notification requirements to placing authorities for clients enrolled in health care programs
ARTICLE 2 - CHEMICAL AND MENTAL HEALTH
Specifying eligibility for placement in opioid treatment programs
ARTICLE 3 - CONTROLLED SUBSTANCES PRESCRIPTION MONITORING PROGRAM
Modifying the definition of hallucinogen; making conforming additions to schedule I substances; allowing commissioner of human services controlled substance reporting system data access for purposes of establishing and implementing a system to determine additional controlled substance prescriptions for opioid treatment program patients, requiring treatment center medical director disclosure under certain conditions
(je)